H.U. Group Holdings, Inc., through its subsidiaries, provides laboratory testing products and services in Japan. The company offers lab testing and its related services to medical institutions; self-medication services; food, environment, and cosmetic testing services; and testing services through corporate health insurance associations. It also researches, develops, manufactures, and sells in vitro diagnostic devices, which includes the LUMIPULSE, an automatic chemiluminescent enzyme immunoassay system that offers reagents for infectious disease, cancer, and lifestyle disease to medical institutions and testing centers; and ESPRINE, a rapid diagnostics kit series for influenza, hepatitis B, and the novel coronavirus, as well as supplies ingredients for test drugs. In addition, the company provides support services related to hospital administration work, including aid for surgical procedures and endoscope room work, inspection and maintenance services for medical equipment, and in-hospital logistics management and transportation services; and rents and sells nursing-care equipment and supplies. Further, it offers home-visit nursing care services. The company was formerly known as Miraca Holdings Inc. and changed its name to H.U. Group Holdings, Inc. in July 2020. H.U. Group Holdings, Inc. was incorporated in 1950 and is headquartered in Tokyo, Japan.

H.U. Group Holdings, Inc.

Omninext provides business consulting and digital solutions, working with both private and public enterprises to enhance their potential through specialized and interconnected digital solutions.

Omninext

H.U. Group Holdings, Inc. is involved in lab testing and related services, in-vitro diagnostics, healthcare-related services, and research and development. The description is self-described.

Metric
Company Name	H.U. Group Holdings, Inc.	Omninext
Symbol	4.54K
MSH ID	COM:HUGP	IT:OMNINEXT
Market	STOCKS	PRIVATE
Sector	Healthcare	Commercial & Professional Services
Industry	Medical - Diagnostics & Research	Information Technology
Country	JP	IT
Stage
Employee Count	5.29K
Website	hugp.com	omninext.it
LinkedIn
Founders

Metric
Market Cap	917.59M
Enterprise Value
Monthly Web Traffic		741
Web Traffic Growth		0.09
Valuation
Raised Capital

Metric
Revenue	1.58B
Revenue (LTM)
Revenue (NTM)
Gross Profit	381.91M
EBITDA	112.22M
Operating Income	-26.97M
Net Income	-50.37M
EPS	-0.89
Diluted EPS	-0.89
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.28
Operating Profit Margin	-0.01
EBITDA Margin	0.07
Net Profit Margin	-0.03
Return on Equity	-0.04
Return on Assets	-0.02
Return on Capital Employed	-0.01

4544

COM:HUGP

H.U. Group Holdings, Inc.

Last Close

2,429.00

25/11 06:45

Market Cap

137.53B

Beta: -

Volume Today

184.60K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	-93.20
P/B Ratio	1.05
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	0.65
EV Multiple	7.05

Metric
Days Sales Outstanding	72.67
Days Payables Outstanding	36.90
Days Inventory Outstanding	50.32
Operating Cycle	122.36
Cash Conversion Cycle	81.16
Asset Turnover	0.84

Metric
Operating Cash Flow	110.38M
Free Cash Flow	-6.71M
Cash Flow to Debt	0.36
Operating Cash Flow/Sales	0.10
Free Cash Flow Yield	0.03

Metric
Cash & Equivalents	266.42M
Accounts Receivable	4.27M
Inventory	149.80M
Goodwill	49.35M
Debt to Capitalization	0.34
Debt to Assets	0.22
Current Ratio	2.43
Quick Ratio	1.57

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue